Login / Signup

Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction.

Kazuhiko KidoChristopher BiancoMarco CaccamoMasayuki HashiguchiLyn Yuen ChooGeorge Sokos
Published in: Journal of pharmacy practice (2023)
The use of sacubitril/valsartan did not significantly change the use or dose of loop diuretics over 6-month follow-up period. Initiation of sacubitril/valsartan may not need a pre-emptive loop diuretic dose reduction.
Keyphrases
  • ejection fraction
  • transcription factor
  • heart failure
  • acute heart failure
  • atrial fibrillation